TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
59.83
+1.85 (3.18%)
At close: Nov 6, 2026, 4:00 PM EST
59.75
-0.08 (-0.13%)
After-hours: Nov 6, 2026, 7:45 PM EST
TG Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 240.34 | 204.92 | 192.57 | 161.71 | 141.15 | 120.86 | 108.19 | 83.88 | 73.47 | 63.47 | 43.97 | 165.82 | 16.07 | 7.8 | 0.08 | 0.09 | 0.59 | 2.02 | 2.32 | 2.03 | |
Revenue Growth (YoY) | 70.27% | 69.56% | 78.00% | 92.79% | 92.13% | 90.40% | 146.04% | -49.41% | 357.05% | 713.46% | 54863.75% | 176298.94% | 2606.06% | 287.05% | -96.55% | -95.37% | -61.55% | 154.22% | 6007.89% | 5242.11% |
Cost of Revenue | 41.19 | 33.51 | 38.14 | 28.09 | 18.94 | 15.54 | 15.4 | 9.34 | 8.3 | 5.44 | 7.85 | 3.51 | 1.91 | 0.86 | 0 | 0 | 0.02 | 0.24 | 0.21 | 0.29 |
Gross Profit | 199.14 | 171.41 | 154.43 | 133.62 | 122.21 | 105.32 | 92.79 | 74.54 | 65.16 | 58.03 | 36.12 | 162.31 | 14.16 | 6.95 | 0.08 | 0.09 | 0.57 | 1.78 | 2.11 | 1.74 |
Selling, General & Admin | 82.13 | 88.22 | 62.75 | 63.37 | 55.59 | 50.33 | 38.96 | 41.97 | 38.79 | 34.58 | 31.15 | 32.77 | 30.72 | 28.07 | 22.5 | 14.25 | 12.64 | 20.61 | 32.41 | 34.9 |
Research & Development | 95.34 | 48.4 | 41.19 | 40.88 | 31.78 | 46.36 | 23.87 | 20.14 | 17.56 | 32.72 | 17.45 | 14.75 | 28.12 | 15.87 | 29.64 | 20.8 | 26.87 | 48.04 | 62.65 | 51.97 |
Operating Expenses | 177.47 | 136.61 | 103.94 | 104.25 | 87.37 | 96.69 | 62.84 | 62.1 | 56.35 | 67.3 | 48.6 | 47.52 | 58.84 | 43.94 | 52.14 | 35.06 | 39.51 | 68.65 | 95.06 | 86.87 |
Operating Income | 21.67 | 34.8 | 50.49 | 29.37 | 34.84 | 8.62 | 29.95 | 12.43 | 8.82 | -9.27 | -12.49 | 114.78 | -44.67 | -36.99 | -52.06 | -34.96 | -38.94 | -66.87 | -92.95 | -85.13 |
Interest Expense | -16.57 | -7.67 | -6.53 | -6.72 | -6.72 | -6.76 | -7.06 | -10.83 | -3.98 | -2.29 | -2.43 | -3.71 | -3.63 | -2.84 | -2.86 | -1.65 | -3.02 | -2.66 | -1.08 | -1.04 |
Other Non Operating Income (Expenses) | 5.13 | 2.39 | 1.13 | 3.27 | 2.79 | 3.6 | 2.57 | 2.67 | 1.71 | 0.88 | 0.89 | 2.86 | 0.69 | 0.6 | 1.93 | 0.79 | 1.45 | 0.52 | 0.69 | 0.53 |
EBT Excluding Unusual Items | 10.23 | 29.52 | 45.09 | 25.91 | 30.92 | 5.47 | 25.45 | 4.27 | 6.55 | -10.68 | -14.03 | 113.93 | -47.61 | -39.23 | -52.99 | -35.82 | -40.51 | -69.01 | -93.34 | -85.64 |
Other Unusual Items | - | -9.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | 10.23 | 20.36 | 45.09 | 25.91 | 30.92 | 5.47 | 25.45 | 4.27 | 6.55 | -10.68 | -14.03 | 113.93 | -47.61 | -39.23 | -52.99 | -35.82 | -40.51 | -69.01 | -93.34 | -85.64 |
Income Tax Expense | 2.45 | 0.59 | 22.06 | -364.99 | 2.73 | 0.41 | 2.12 | 0.39 | -0.33 | 0.03 | 0.39 | - | - | - | - | - | - | - | - | - |
Net Income | 7.78 | 19.78 | 23.04 | 390.9 | 28.19 | 5.06 | 23.33 | 3.88 | 6.88 | -10.71 | -14.42 | 113.93 | -47.61 | -39.23 | -52.99 | -35.82 | -40.51 | -69.01 | -93.34 | -85.64 |
Net Income to Common | 7.78 | 19.78 | 23.04 | 390.9 | 28.19 | 5.06 | 23.33 | 3.88 | 6.88 | -10.71 | -14.42 | 113.93 | -47.61 | -39.23 | -52.99 | -35.82 | -40.51 | -69.01 | -93.34 | -85.64 |
Net Income Growth (YoY) | -72.39% | 290.85% | -1.26% | 9974.61% | 309.75% | - | - | -96.59% | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 142 | 144 | 143 | 145 | 147 | 147 | 145 | 145 | 145 | 146 | 143 | 143 | 142 | 140 | 137 | 135 | 135 | 134 | 133 | 132 |
Shares Outstanding (Diluted) | 157 | 160 | 159 | 161 | 163 | 163 | 160 | 161 | 159 | 146 | 143 | 156 | 142 | 140 | 137 | 135 | 135 | 134 | 133 | 132 |
Shares Change (YoY) | -3.25% | -1.66% | -0.55% | 0.18% | 1.97% | 11.33% | 11.99% | 3.11% | 12.66% | 4.20% | 4.36% | 15.18% | 4.99% | 4.40% | 3.43% | 2.25% | 2.05% | 1.90% | 6.74% | 11.06% |
EPS (Basic) | 0.05 | 0.14 | 0.16 | 2.69 | 0.19 | 0.03 | 0.16 | 0.03 | 0.05 | -0.07 | -0.10 | 0.80 | -0.34 | -0.28 | -0.39 | -0.26 | -0.30 | -0.51 | -0.70 | -0.65 |
EPS (Diluted) | 0.05 | 0.12 | 0.14 | 2.43 | 0.17 | 0.03 | 0.15 | 0.02 | 0.04 | -0.07 | -0.10 | 0.73 | -0.34 | -0.28 | -0.39 | -0.26 | -0.30 | -0.51 | -0.70 | -0.65 |
EPS Growth (YoY) | -70.59% | 300.01% | -6.13% | 12049.99% | 325.00% | - | - | -97.26% | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | 38.97 | -17.95 | 19.59 | -23.23 | 7.39 | -28.74 | -25.66 | -12.23 | 5.54 | -8.21 | -13.21 | 83.7 | -42.01 | -59.9 | -23.87 | -34.5 | -49.12 | -68.7 | -86.99 | -67.28 |
Free Cash Flow Per Share | 0.25 | -0.11 | 0.12 | -0.14 | 0.04 | -0.18 | -0.16 | -0.08 | 0.04 | -0.06 | -0.09 | 0.54 | -0.30 | -0.43 | -0.17 | -0.26 | -0.36 | -0.51 | -0.66 | -0.51 |
Gross Margin | 82.86% | 83.65% | 80.19% | 82.63% | 86.58% | 87.14% | 85.77% | 88.86% | 88.70% | 91.43% | 82.14% | 97.88% | 88.11% | 89.02% | 96.25% | 97.87% | 96.13% | 88.24% | 90.95% | 85.62% |
Operating Margin | 9.02% | 16.98% | 26.22% | 18.16% | 24.69% | 7.13% | 27.68% | 14.82% | 12.00% | -14.60% | -28.39% | 69.22% | -277.93% | -474.07% | -65077.50% | -37194.68% | -6555.72% | -3317.06% | -4004.61% | -4193.50% |
Profit Margin | 3.24% | 9.65% | 11.96% | 241.73% | 19.97% | 4.19% | 21.57% | 4.63% | 9.36% | -16.87% | -32.78% | 68.71% | -296.19% | -502.78% | -66242.50% | -38104.25% | -6819.86% | -3423.26% | -4021.46% | -4218.57% |
Free Cash Flow Margin | 16.21% | -8.76% | 10.17% | -14.37% | 5.24% | -23.78% | -23.72% | -14.58% | 7.54% | -12.93% | -30.04% | 50.48% | -261.32% | -767.68% | -29841.25% | -36701.06% | -8268.69% | -3407.54% | -3747.91% | -3314.29% |
EBITDA | 21.73 | 34.83 | 50.52 | 29.38 | 34.86 | 8.63 | 29.96 | 12.45 | 8.84 | -9.24 | -12.45 | 114.86 | -44.64 | -36.92 | -51.99 | -34.89 | -38.86 | -66.8 | -92.87 | -85.05 |
EBITDA Margin | 9.04% | 17.00% | 26.23% | 18.17% | 24.70% | 7.14% | 27.69% | 14.84% | 12.03% | -14.56% | -28.31% | 69.27% | -277.73% | - | - | - | - | - | - | - |
D&A For EBITDA | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.07 | 0.03 | 0.07 | 0.07 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
EBIT | 21.67 | 34.8 | 50.49 | 29.37 | 34.84 | 8.62 | 29.95 | 12.43 | 8.82 | -9.27 | -12.49 | 114.78 | -44.67 | -36.99 | -52.06 | -34.96 | -38.94 | -66.87 | -92.95 | -85.13 |
EBIT Margin | 9.02% | 16.98% | 26.22% | 18.16% | 24.69% | 7.13% | 27.68% | 14.82% | 12.00% | -14.60% | -28.39% | 69.22% | -277.93% | - | - | - | - | - | - | - |
Effective Tax Rate | 23.97% | 2.88% | 48.91% | - | 8.84% | 7.46% | 8.34% | 9.09% | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue as Reported | 240.34 | 204.92 | 192.57 | 161.71 | 141.15 | 120.86 | 108.19 | 83.88 | 73.47 | 63.47 | 43.97 | 165.82 | 16.07 | 7.8 | 0.08 | 0.09 | 0.59 | 2.02 | 2.32 | 2.03 |